Journal
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
Volume 323, Issue 1, Pages C29-C45Publisher
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpcell.00024.2022
Keywords
cancer; CD138; proteoglycan; syndecan-1; therapy
Categories
Ask authors/readers for more resources
This review summarizes the current knowledge on the structure and functions of Syndecan-1 (SDC1) and its role in tumor biology. The review highlights the critical role of SDC1 in promoting tumorigenesis and metastasis, and emphasizes the potential of utilizing SDC1 as a novel target for cancer therapy.
Syndecan-1 (SDC1, CD138) is one of the heparan sulfate proteoglycans and is essential for maintaining normal cell morphology, interacting with the extracellular and intracellular protein repertoire, as well as mediating signaling transduction upon environmental stimuli. The critical role of SDC1 in promoting tumorigenesis and metastasis has been increasingly recognized in various cancer types, implying a promising potential of utilizing SDC1 as a novel target for cancer therapy. This review summarizes the current knowledge on SDC1 structure and functions, including its role in tumor biology. We also discuss the highlights and limitations of current SDC1-targeted therapies as well as the obstacles in developing new therapeutic methods, offering our perspective on the future directions to target SDC1 for cancer treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available